Comparing the effectiveness of phenytoin, Levetiracetam , and valproic acid in preventing seizures in hemorrhage caused by brain trauma.
Design
Clinical trial with 3 intervention groups, with parallel groups, Double-blind, randomized, phase 3 on 225 patients. Block method was used for randomization with randomization.com online software.
Settings and conduct
225 brain trauma patients referred to Valiasr Hospital in Arak city, who were randomly divided into 3 groups and received one of the 3 commonly used injectable anticonvulsant drugs available in Iran . Then they will be evaluated within the first 24 hours and then up to 6 days.This study is double-blind and the patients or their legal guardians
and the intern are not aware of the type of drug received, but the project manager and the analyzer will be aware of the type of drug received
Participants/Inclusion and exclusion criteria
Inclusion criteria: head trauma that requires prophylactic anticonvulsant treatment. Exclusion criteria: pregnancy, History of epilepsy, history of allergy to studied drugs
Intervention groups
In the first intervention group, patients are treated with phenytoin with a loading dose of 20 mg/kg and injection within one hour and a maintenance dose of 5 mg/kg every day. First, they receive injectable medicine for 24 to 48 hours and then oral medicine. The second group: treatment with the drug Levetiracetam with a loading dose of 20 mg/kg and injection within one hour and a maintenance dose of 10 to 20 mg/kg per day. Patients first receive injectable medicine for 24 to 48 hours and then oral medicine.The third group: First, 15 mg/kg sodium valproate is administered by injection, and a maintenance dose of 15 mg/kg is administered in 2 to 3 divided doses every day. The patient first receives injectable medicine for 24 to 48 hours and then oral medicine.
Main outcome variables
Number of seizures
General information
Reason for update
Acronym
IRCT registration information
IRCT registration number:IRCT20240617062155N1
Registration date:2024-08-10, 1403/05/20
Registration timing:registered_while_recruiting
Last update:2024-08-10, 1403/05/20
Update count:0
Registration date
2024-08-10, 1403/05/20
Registrant information
Name
benyamin beyrami
Name of organization / entity
Country
Iran (Islamic Republic of)
Phone
+98 86 4417 3304
Email address
benyamin.medicine@gmail.com
Recruitment status
Recruitment complete
Funding source
Expected recruitment start date
2024-08-01, 1403/05/11
Expected recruitment end date
2024-09-30, 1403/07/09
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
Comparison of the effectiveness of phenytoin and Levetiracetam and valproic acid in prevention of seizure of post traumatic brain hemorrahage
Public title
effectiveness of phenytoin and Levetiracetam and valproic acid in prevention of seizure of brain hemorrahage
Purpose
Treatment
Inclusion/Exclusion criteria
Inclusion criteria:
Head trauma requiring prophylactic anticonvulsant treatment
Exclusion criteria:
Pregnancy
History of epilepsy
Allergy to the studied drugs
Age
No age limit
Gender
Both
Phase
3
Groups that have been masked
Participant
Outcome assessor
Sample size
Target sample size:
225
Randomization (investigator's opinion)
Randomized
Randomization description
Randomization in this study will be done using block randomization method. In this way, 225 blocks of 3 were created randomly using randomization.com online software by the plan's statistical consultant and sealed in 225 envelopes with aluminum cover and numbered in the order of creation. Then, during the implementation of the plan, the created sequences will be removed from the envelopes and the patients will be assigned to groups A, B and C based on the sequence of each block.
Blinding (investigator's opinion)
Double blinded
Blinding description
Patients will be assigned to each treatment based on block randomization method.The study procedure and the requirement to receive an anticonvulsant drug after severe traumatic brain injury, which is one of the 3 injectable drugs available in Iran which are also the subject of our study, will be explained to patients or their legal guardians, and informed consent will be obtained. However, the patients or their legal guardian will not be aware of the type of drug received (out of the 3 drugs). Additionally, the medical intern, who is responsible for collecting data, will not be aware of the drug received and will recognize them into groups A, B, or C ; the project manager and the data analyst will be aware of the type of drug received by the patients.
Placebo
Not used
Assignment
Parallel
Other design features
Secondary Ids
empty
Ethics committees
1
Ethics committee
Name of ethics committee
Ethics committee of Arak University of Medical Sciences
Street address
Payambar-e-azam complex, Sardasht Town
City
Arak
Province
Markazi
Postal code
3848176341
Approval date
2024-05-18, 1403/02/29
Ethics committee reference number
IR.ARAKMU.REC.1403.051
Health conditions studied
1
Description of health condition studied
traumatic intracerebral haemorrhage
ICD-10 code
S06.3
ICD-10 code description
Focal traumatic brain injury
Primary outcomes
1
Description
Seizure
Timepoint
The first day to a week after starting the study
Method of measurement
Clinical observation
Secondary outcomes
empty
Intervention groups
1
Description
Intervention group 1: In this group, the patients are treated with the anticonvulsant drug phenytoin (Caspian-Iran) with a loading dose of 20 mg/kg and injection within one hour and a maintenance dose of 5 mg/kg every day, which the patients first receive injectable drug for 24 to 48 hours and then They receive oral drug. Phenytoin is taken from Caspian Tamin-Iran pharmaceutical company. It is one of the three common anti-seizure medications used in Iran to prevent seizures caused by traumatic brain injury
Category
Treatment - Drugs
2
Description
Intervention group 2: In this group, patients are treated with the anticonvulsant drug Levetiracetam (Arang-Iran) with a loading dose of 20 mg/kg and an injection within one hour and a maintenance dose of 10 to 20 mg/kg every day. They receive for 24-48 hours injectable and then oral medicine. Levetiracetam is taken from Arang-Iran Daro Darman pharmaceutical company . It is one of the three common anti-seizure medications used in Iran to prevent seizures caused by traumatic brain injury
Category
Treatment - Drugs
3
Description
Intervention group 3: In this group, 15 mg/kg of the anticonvulsant drug sodium valproate (Arang-Iran) injection is first prescribed for patients, and the maintenance dose is 15 mg/kg in 2 to 3 divided doses every day. Patients first receive injectable medicine for 24 to 48 hours and then orally. The sodium valproate is taken from Daro Derman Arang-Iran pharmaceutical company.It is one of the three common anti-seizure medications used in Iran to prevent seizures caused by traumatic brain injury
Category
Treatment - Drugs
Recruitment centers
1
Recruitment center
Name of recruitment center
Valiasr hospital
Full name of responsible person
Benyamin Beyrami
Street address
Valiasr sq.
City
Arak
Province
Markazi
Postal code
3814957558
Phone
+98 86 2332 1283
Email
pr_valieasr@arakmu.ac.ir
Sponsors / Funding sources
1
Sponsor
Name of organization / entity
Arak University of Medical Sciences
Full name of responsible person
Davud Hekmatpou
Street address
Payambar-e-azam complex, Sardasht Town
City
Arak
Province
Markazi
Postal code
3848176341
Phone
+98 86 3314 3724
Email
research@arakmu.ac.ir
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
Arak University of Medical Sciences
Proportion provided by this source
100
Public or private sector
Public
Domestic or foreign origin
Domestic
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
Academic
Person responsible for general inquiries
Contact
Name of organization / entity
Arak University of Medical Sciences
Full name of responsible person
Benyamin Beyrami
Position
Student
Latest degree
A Level or less
Other areas of specialty/work
General Practitioner
Street address
Payambar-e-azam complex, Sardasht Town
City
Arak
Province
Markazi
Postal code
3814957558
Phone
+98 86 3314 4712
Email
benyamin.medicine@gmail.com
Person responsible for scientific inquiries
Contact
Name of organization / entity
Arak University of Medical Sciences
Full name of responsible person
Benyamin Beyrami
Position
Student
Latest degree
A Level or less
Other areas of specialty/work
General Practitioner
Street address
Payambar-e-azam complex, Sardasht Town
City
Arak
Province
Markazi
Postal code
3814957558
Phone
+98 86 3314 4712
Email
benyamin.medicine@gmail.com
Person responsible for updating data
Contact
Name of organization / entity
Arak University of Medical Sciences
Full name of responsible person
Benyamin Beyrami
Position
Student
Latest degree
A Level or less
Other areas of specialty/work
General Practitioner
Street address
Payambar-e-azam complex, Sardasht Town
City
Arak
Province
Markazi
Postal code
3814957558
Phone
+98 86 3314 4712
Email
benyamin.medicine@gmail.com
Sharing plan
Deidentified Individual Participant Data Set (IPD)
Undecided - It is not yet known if there will be a plan to make this available
Study Protocol
Undecided - It is not yet known if there will be a plan to make this available
Statistical Analysis Plan
Undecided - It is not yet known if there will be a plan to make this available
Informed Consent Form
Undecided - It is not yet known if there will be a plan to make this available
Clinical Study Report
Undecided - It is not yet known if there will be a plan to make this available
Analytic Code
Undecided - It is not yet known if there will be a plan to make this available
Data Dictionary
Undecided - It is not yet known if there will be a plan to make this available